Therapie genetischer Krankheiten

  • Gholamali Tariverdian
  • Marion Paul


Bereits vor Jahren hat man mit der Therapie genetischer Krankheiten begonnen. Die Therapie war zunächst nur symptomatisch, wie z. B. die Gabe von Erythrozytenkonzentraten bei Hämoglobinopathien oder die Faktor-VIII-Substitution bei Hämophilie.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson WF (1992) Human gene therapy. Science 256:808–813PubMedCrossRefGoogle Scholar
  2. Friedmann T (ed) (1991) Therapy of genetic disease. Oxford University PressGoogle Scholar
  3. Harrison MR, Golbus MS, Filly RA (1984) The unborn patient. Prenatal diagnosis and treatment. Grune & Stratton, LondonGoogle Scholar
  4. Manning FA, Harrison MR, Rodeck CH (1986) Catheter shunts for fetal hydronephrosis and hydrocephalus. Report of the International Fetal Surgery Registry. N Engl J Med 315:336–340PubMedCrossRefGoogle Scholar
  5. Nicolaides KH, Rodeck CH (1985) Fetal therapy. In: Studd J (ed) Progress in obstetrics and gynecology, vol 5. Churchill Livingstone, Edinburgh, pp 40–57Google Scholar
  6. Report of the Committee on the Ethics of Gene Therapy (1992) The recommendations of the committee chaired by Sir Cecil Clothier on the ethical of somatic cell and germ-line gene therapy. HMSO, LondonGoogle Scholar
  7. Rosenfeld M (1992) In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143–155PubMedCrossRefGoogle Scholar
  8. Vogel F, Motulsky AG (1996) Human genetics, problems and approaches, 3rd edn. Springer, Berlin Heidelberg New York TokyoGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Gholamali Tariverdian
    • 1
  • Marion Paul
    • 2
  1. 1.Institut für Humangenetik der Universität Heidelberg Genetische PoliklinikHeidelbergGermany
  2. 2.Gemeinschaftspraxis Drs. med. M. Paul, M. Chwat, M. GastMannheimGermany

Personalised recommendations